Glioblastoma Treatment: UCSF Startup Turns Brain Tumors Into Immune Cell Factories
A UCSF-spun startup backed by Andreessen Horowitz and Y Combinator announced today that it has closed a $9.1 million seed round to advance a genetically engineered virus into its first human clinical trial — one targeting glioblastoma, the most lethal form …